ADA-USD over past 60 days: cumulative return -20.9%, annualized vol 94.7%. Market regime: sideways.

Question:
Asset: ADA-USD
Historical prices (past 60 trading days): start=0.93, end=0.74, cumulative_return=-20.9%, annualized_volatility=94.7%
Macro context: {'fed_funds_rate': 4.33, 'cpi_yoy': 319.785, 'unemployment': 4.2, 'gdp_growth_qoq': 23548.21, 't10y2y_spread': 0.41, 't10y3m_spread': 0.05, 'breakeven_10y': 2.39, 'hy_oas': 3.27, 'ig_oas': 0.91, 'ted_spread': 0.09, 'mortgage_30y': 6.65, 'vix': 18.690000534057617}
Market regime: sideways
Recent filing/news:
[Kaggle 2023-12-19]

Predict whether the return of ADA-USD over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: negative

Explanation: The actual 21-day forward return for ADA-USD starting 2025-03-28 was -11.07%, which classifies as 'negative'.


SOL-USD over past 60 days: cumulative return -9.1%, annualized vol 52.8%. Market regime: sideways.

Question:
Asset: SOL-USD
Historical prices (past 60 trading days): start=173.03, end=157.28, cumulative_return=-9.1%, annualized_volatility=52.8%
Macro context: {'fed_funds_rate': 4.33, 'cpi_yoy': 322.169, 'unemployment': 4.3, 'gdp_growth_qoq': 24026.834, 't10y2y_spread': 0.48, 't10y3m_spread': -0.08, 'breakeven_10y': 2.33, 'hy_oas': 2.94, 'ig_oas': 0.83, 'ted_spread': 0.09, 'mortgage_30y': 6.67, 'vix': 15.9399995803833}
Market regime: sideways
Recent filing/news:
[Kaggle 2023-12-19]

Predict whether the return of SOL-USD over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: positive

Explanation: The actual 21-day forward return for SOL-USD starting 2025-07-10 was +5.10%, which classifies as 'positive'.


ETH-USD over past 60 days: cumulative return -29.0%, annualized vol 54.6%. Market regime: sideways.

Question:
Asset: ETH-USD
Historical prices (past 60 trading days): start=3980.76, end=2827.07, cumulative_return=-29.0%, annualized_volatility=54.6%
Macro context: {'fed_funds_rate': 3.64, 'cpi_yoy': 326.031, 'unemployment': 4.4, 'gdp_growth_qoq': 24055.749, 't10y2y_spread': 0.66, 't10y3m_spread': 0.5, 'breakeven_10y': 2.24, 'hy_oas': 2.95, 'ig_oas': 0.81, 'ted_spread': 0.09, 'mortgage_30y': 6.21, 'vix': 16.8700008392334}
Market regime: sideways
Recent filing/news:
[Kaggle 2023-12-19]

Predict whether the return of ETH-USD over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: flat

Explanation: The actual 21-day forward return for ETH-USD starting 2025-12-19 was -0.37%, which classifies as 'flat'.


VEA over past 60 days: cumulative return +7.5%, annualized vol 18.3%. Market regime: sideways.

Question:
Asset: VEA
Historical prices (past 60 trading days): start=48.44, end=52.06, cumulative_return=+7.5%, annualized_volatility=18.3%
Macro context: {'fed_funds_rate': 4.33, 'cpi_yoy': 320.62, 'unemployment': 4.3, 'gdp_growth_qoq': 23770.976, 't10y2y_spread': 0.53, 't10y3m_spread': 0.03, 'breakeven_10y': 2.28, 'hy_oas': 3.6, 'ig_oas': 1.05, 'ted_spread': 0.09, 'mortgage_30y': 6.76, 'vix': 23.63999938964844}
Market regime: sideways
Recent filing/news:
[SEC 10-Q PFE 2025-05-05] pfe-20250330 0000078003 12/31 2025 Q1 false P1Y P3Y P5Y P7Y xbrli:shares iso4217:USD iso4217:USD xbrli:shares pfe:segment xbrli:pure pfe:company pfe:patent pfe:complaint pfe:treatment_course 0000078003 2025-01-01 2025-03-30 0000078003 us-gaap:CommonStockMember 2025-01-01 2025-03-30 0000078003 pfe:NotesDue20271.000Member 2025-01-01 2025-03-30 0000078003 2025-04-30 0000078003 us-gaap:ProductMember 2025-01-01 2025-03-30 0000078003 us-gaap:ProductMember 2024-01-01 2024-03-31 0000078003 2024-01-01 2024-03-31 0000078003 us-gaap:RoyaltyMember 2025-01-01 2025-03-30 0000078003 us-gaap:RoyaltyMember 2024-01-01 2024-03-31 0000078003 2025-03-30 0000078003 2024-12-31 0000078003 us-gaap:CommonStockMember 2024-12-31 0000078003 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000078003 us-gaap:TreasuryStockCommonMember 2024-12-31 0000078003 us-gaap:RetainedEarningsMember 2024-12-31 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0000078003 us-gaap:ParentMember 2024-12-31 0000078003 us-gaap:NoncontrollingInterestMember 2024-12-31 0000078003 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-30 0000078003 us-gaap:ParentMember 2025-01-01 2025-03-30 0000078003 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-30 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-30 0000078003 us-gaap:CommonStockMember 2025-01-01 2025-03-30 0000078003 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-30 0000078003 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-30 0000078003 us-gaap:CommonStockMember 2025-03-30 0000078003 us-gaap:AdditionalPaidInCapitalMember 2025-03-30 0000078003 us-gaap:TreasuryStockCommonMember 2025-03-30 0000078003 us-gaap:RetainedEarningsMember 2025-03-30 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-30 0000078003 us-gaap:ParentMember 2025-03-30 0000078003 us-gaap:NoncontrollingInterestMember 2025-03-30 0000078003 us-gaap:CommonStockMember 2023-12-31 0000078003 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000078003 us-gaap:TreasuryStockCommonMember 2023-12-31 0000078003 us-gaap:RetainedEarningsMember 2023-12-31 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000078003 us-gaap:ParentMember 2023-12-31 0000078003 us-gaap:NoncontrollingInterestMember 2023-12-31 0000078003 2023-12-31 0000078003 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000078003 us-gaap:ParentMember 2024-01-01 2024-03-31 0000078003 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000078003 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000078003 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000078003 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0000078003 us-gaap:CommonStockMember 2024-03-31 0000078003 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000078003 us-gaap:TreasuryStockCommonMember 2024-03-31 0000078003 us-gaap:RetainedEarningsMember 2024-03-31 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000078003 us-gaap:ParentMember 2024-03-31 0000078003 us-gaap:NoncontrollingInterestMember 2024-03-31 0000078003 2024-03-31 0000078003 us-gaap:AccountsReceivableMember 2025-03-30 0000078003 us-gaap:AccountsReceivableMember 2024-12-31 0000078003 us-gaap:OtherCurrentLiabilitiesMember 2025-03-30 0000078003 us-gaap:OtherCurrentLiabilitiesMember 2024-12-31 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember 2025-03-30 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember 2024-12-31 0000078003 pfe:BlackstoneMember 2025-03-01 2025-03-30 0000078003 pfe:ClinicalTrialAgreementTermsMember pfe:BlackstoneMember 2025-03-30 0000078003 pfe:ApprovalBasedPaymentPeriodMember pfe:BlackstoneMember srt:MinimumMember 2025-03-30 0000078003 pfe:ApprovalBasedPaymentPeriodMember pfe:BlackstoneMember srt:MaximumMember 2025-03-30 0000078003 pfe:NetSalesAndRoyaltyAgreementTermsMember pfe:BlackstoneMember 2025-03-30 0000078003 pfe:NetSalesAndRoyaltyAgreementTermsMember pfe:BlackstoneMember srt:MinimumMember 2025-03-30 0000078003 pfe:NetSalesAndRoyaltyAgreementTermsMember pfe:BlackstoneMember srt:MaximumMember 2025-03-30 0000078003 pfe:RealigningOurCostBaseProgramInitialPhaseMember 2025-03-30 0000078003 pfe:RealigningOurCostBaseProgramInitialPhaseMember pfe:BiopharmaSegmentMember 2025-03-30 0000078003 us-gaap:OtherRestructuringMember pfe:RealigningOurCostBaseProgramSellingInformationalAndAdministrativeInitiativeMember us-gaap:SubsequentEventMember 2025-05-05 0000078003 us-gaap:OtherRestructuringMember pfe:RealigningOurCostBaseProgramSellingInformationalAndAdministrativeInitiativeMember us-gaap:SubsequentEventMember pfe:BiopharmaSegmentMember 2025-05-05 0000078003 us-gaap:OtherRestructuringMember pfe:RealigningOurCostBaseProgramResearchAndDevelopmentMember pfe:BiopharmaSegmentMember 2025-03-30 0000078003 pfe:RealigningOurCostBaseProgramMember us-gaap:SubsequentEventMember 2025-05-05 0000078003 pfe:RealigningOurCostBaseProgramMember us-gaap:SubsequentEventMember pfe:BiopharmaSegmentMember 2025-05-05 0000078003 pfe:RealigningOurCostBaseProgramMember 2025-03-30 0000078003 pfe:RealigningOurCostBaseProgramMember pfe:BiopharmaSegmentMember 2025-03-30 0000078003 pfe:RealigningOurCostBaseProgramMember pfe:BiopharmaSegmentMember 2023-10-02 2025-03-30 0000078003 pfe:ManufacturingOptimizationProgramPhaseOneMember pfe:BiopharmaSegmentMember 2025-03-30 0000078003 pfe:ManufacturingOptimizationProgramMember pfe:BiopharmaSegmentMember 2025-03-30 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember 2025-01-01 2025-03-30 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember 2024-01-01 2024-03-31 0000078003 us-gaap:CostOfSalesMember 2025-01-01 2025-03-30 0000078003 us-gaap:CostOfSalesMember 2024-01-01 2024-03-31 0000078003 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2025-01-01 2025-03-30 0000078003 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-01-01 2024-03-31 0000078003 us-gaap:ResearchAnd [...TRUNCATED...] f Shares Purchased as Part of Publicly Announced Plan Approximate Value of Shares That May Yet Be Purchased Under the Plan (b) January 1 through January 26, 2025 25,387  $ 26.65  —  $ 3,292,882,444  January 27 through February 23, 2025 1,107,921  $ 26.29  —  $ 3,292,882,444  February 24 through March 30, 2025 8,191,799  $ 26.23  —  $ 3,292,882,444  Total 9,325,107  $ 26.24  —  50 (a) Represents (i) 9,321,821 shares of common stock surrendered to the Company to satisfy tax withholding obligations in connection with the vesting of awards under our long-term incentive programs and (ii) the open market purchase by the trustee of 3,286 shares of common stock in connection with the reinvestment of dividends paid on common stock held in trust for employees who deferred receipt of performance share awards. (b) See Note 12 in our 2024 Form 10-K. ITEM 5. OTHER INFORMATION During the three months ended March 30, 2025, none of our directors or officers adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K. ITEM 6. EXHIBITS   Exhibit 31.1 Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.   Exhibit 31.2 Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.   Exhibit 32.1 Certification by the Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.   Exhibit 32.2 Certification by the Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.   Exhibit 101:     EX-101.INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.   EX-101.SCH EX-101.CAL EX-101.LAB EX-101.PRE EX-101.DEF   Inline XBRL Taxonomy Extension Schema Inline XBRL Taxonomy Extension Calculation Linkbase Inline XBRL Taxonomy Extension Label Linkbase Inline XBRL Taxonomy Extension Presentation Linkbase Inline XBRL Taxonomy Extension Definition Document Exhibit 104 Cover Page Interactive Data File––the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.   Pfizer Inc.   (Registrant)         Dated: May 5, 2025 /s/ Jennifer B. Damico   Jennifer B. Damico Senior Vice President and Controller (Principal Accounting Officer and Duly Authorized Officer) 51

Predict whether the return of VEA over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: positive

Explanation: The actual 21-day forward return for VEA starting 2025-05-06 was +4.47%, which classifies as 'positive'.


QUAL over past 60 days: cumulative return +0.2%, annualized vol 11.9%. Market regime: sideways.

Question:
Asset: QUAL
Historical prices (past 60 trading days): start=177.56, end=177.84, cumulative_return=+0.2%, annualized_volatility=11.9%
Macro context: {'fed_funds_rate': 4.33, 'cpi_yoy': 318.961, 'unemployment': 4.0, 'gdp_growth_qoq': 23548.21, 't10y2y_spread': 0.34, 't10y3m_spread': 0.27, 'breakeven_10y': 2.34, 'hy_oas': 2.76, 'ig_oas': 0.84, 'ted_spread': 0.09, 'mortgage_30y': 6.91, 'vix': 16.040000915527344}
Market regime: sideways
Recent filing/news:
[SEC 10-Q WMT 2024-12-06] wmt-20241031 0000104169 1/31 2025 Q3 false 451 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure iso4217:JPY wmt:state wmt:county wmt:defendant wmt:case wmt:classAction wmt:securitiesClassAction wmt:shareholder wmt:derivativeAction wmt:pharmacist wmt:segment 0000104169 2024-02-01 2024-10-31 0000104169 wmt:CommonStockparvalue0.10pershareMember 2024-02-01 2024-10-31 0000104169 wmt:A2.550NotesDue2026Member 2024-02-01 2024-10-31 0000104169 wmt:A1050NotesDue2026Member 2024-02-01 2024-10-31 0000104169 wmt:A1500NotesDue2028Member 2024-02-01 2024-10-31 0000104169 wmt:A4875NotesDue2029Member 2024-02-01 2024-10-31 0000104169 wmt:A5750NotesDue2030Member 2024-02-01 2024-10-31 0000104169 wmt:A1800NotesDue2031Member 2024-02-01 2024-10-31 0000104169 wmt:A5625NotesDue2034Member 2024-02-01 2024-10-31 0000104169 wmt:A5250NotesDue2035Member 2024-02-01 2024-10-31 0000104169 wmt:A4875NotesDue2039Member 2024-02-01 2024-10-31 0000104169 2024-12-04 0000104169 2024-08-01 2024-10-31 0000104169 2023-08-01 2023-10-31 0000104169 2023-02-01 2023-10-31 0000104169 2024-10-31 0000104169 2024-01-31 0000104169 2023-10-31 0000104169 us-gaap:CommonStockMember 2024-01-31 0000104169 us-gaap:AdditionalPaidInCapitalMember 2024-01-31 0000104169 us-gaap:RetainedEarningsMember 2024-01-31 0000104169 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-31 0000104169 us-gaap:ParentMember 2024-01-31 0000104169 us-gaap:NoncontrollingInterestMember 2024-01-31 0000104169 us-gaap:RetainedEarningsMember 2024-02-01 2024-04-30 0000104169 us-gaap:ParentMember 2024-02-01 2024-04-30 0000104169 us-gaap:NoncontrollingInterestMember 2024-02-01 2024-04-30 0000104169 2024-02-01 2024-04-30 0000104169 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-02-01 2024-04-30 0000104169 us-gaap:CommonStockMember 2024-02-01 2024-04-30 0000104169 us-gaap:AdditionalPaidInCapitalMember 2024-02-01 2024-04-30 0000104169 us-gaap:CommonStockMember 2024-04-30 0000104169 us-gaap:AdditionalPaidInCapitalMember 2024-04-30 0000104169 us-gaap:RetainedEarningsMember 2024-04-30 0000104169 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-30 0000104169 us-gaap:ParentMember 2024-04-30 0000104169 us-gaap:NoncontrollingInterestMember 2024-04-30 0000104169 2024-04-30 0000104169 us-gaap:RetainedEarningsMember 2024-05-01 2024-07-31 0000104169 us-gaap:ParentMember 2024-05-01 2024-07-31 0000104169 us-gaap:NoncontrollingInterestMember 2024-05-01 2024-07-31 0000104169 2024-05-01 2024-07-31 0000104169 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-05-01 2024-07-31 0000104169 us-gaap:CommonStockMember 2024-05-01 2024-07-31 0000104169 us-gaap:AdditionalPaidInCapitalMember 2024-05-01 2024-07-31 0000104169 us-gaap:CommonStockMember 2024-07-31 0000104169 us-gaap:AdditionalPaidInCapitalMember 2024-07-31 0000104169 us-gaap:RetainedEarningsMember 2024-07-31 0000104169 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-31 0000104169 us-gaap:ParentMember 2024-07-31 0000104169 us-gaap:NoncontrollingInterestMember 2024-07-31 0000104169 2024-07-31 0000104169 us-gaap:RetainedEarningsMember 2024-08-01 2024-10-31 0000104169 us-gaap:ParentMember 2024-08-01 2024-10-31 0000104169 us-gaap:NoncontrollingInterestMember 2024-08-01 2024-10-31 0000104169 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-08-01 2024-10-31 0000104169 us-gaap:CommonStockMember 2024-08-01 2024-10-31 0000104169 us-gaap:AdditionalPaidInCapitalMember 2024-08-01 2024-10-31 0000104169 us-gaap:CommonStockMember 2024-10-31 0000104169 us-gaap:AdditionalPaidInCapitalMember 2024-10-31 0000104169 us-gaap:RetainedEarningsMember 2024-10-31 0000104169 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-10-31 0000104169 us-gaap:ParentMember 2024-10-31 0000104169 us-gaap:NoncontrollingInterestMember 2024-10-31 0000104169 us-gaap:CommonStockMember 2023-01-31 0000104169 us-gaap:AdditionalPaidInCapitalMember 2023-01-31 0000104169 us-gaap:RetainedEarningsMember 2023-01-31 0000104169 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-31 0000104169 us-gaap:ParentMember 2023-01-31 0000104169 us-gaap:NoncontrollingInterestMember 2023-01-31 0000104169 2023-01-31 0000104169 us-gaap:RetainedEarningsMember 2023-02-01 2023-04-30 0000104169 us-gaap:ParentMember 2023-02-01 2023-04-30 0000104169 us-gaap:NoncontrollingInterestMember 2023-02-01 2023-04-30 0000104169 2023-02-01 2023-04-30 0000104169 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-02-01 2023-04-30 0000104169 us-gaap:CommonStockMember 2023-02-01 2023-04-30 0000104169 us-gaap:AdditionalPaidInCapitalMember 2023-02-01 2023-04-30 0000104169 us-gaap:CommonStockMember 2023-04-30 0000104169 us-gaap:AdditionalPaidInCapitalMember 2023-04-30 0000104169 us-gaap:RetainedEarningsMember 2023-04-30 0000104169 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-30 0000104169 us-gaap:ParentMember 2023-04-30 0000104169 us-gaap:NoncontrollingInterestMember 2023-04-30 0000104169 2023-04-30 0000104169 us-gaap:RetainedEarningsMember 2023-05-01 2023-07-31 0000104169 us-gaap:ParentMember 2023-05-01 2023-07-31 0000104169 us-gaap:NoncontrollingInterestMember 2023-05-01 2023-07-31 0000104169 2023-05-01 2023-07-31 0000104169 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-05-01 2023-07-31 0000104169 us-gaap:CommonStockMember 2023-05-01 2023-07-31 0000104169 us-gaap:AdditionalPaidInCapitalMember 2023-05-01 2023-07-31 0000104169 us-gaap:CommonStockMember 2023-07-31 0000104169 us-gaap:AdditionalPaidInCapitalMember 2023-07-31 0000104169 us-gaap:RetainedEarningsMember 2023-07-31 0000104169 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-31 0000104169 us-gaap:ParentMember 2023-07-31 0000104169 us-gaap:NoncontrollingInterestMember 2023-07-31 0000104169 2023-07-31 0000104169 us-gaap:RetainedEarningsMember 2023-08-01 2023-10-31 0000104169 us-gaap:ParentMember 2023-08-01 2023-10-31 0000104169 us-gaap:NoncontrollingInterestMember 2023-08-01 2023-10-31 0000104169 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-08-01 2023-10-31 0000104169 us-gaap:Com [...TRUNCATED...] assumptions not being realized or other factors, the actual results relating to the subject matter of any forward-looking statement in this Quarterly Report on Form 10-Q may differ materially from the anticipated results expressed or implied in that forward-looking statement. The forward-looking statements included in this Quarterly Report on Form 10-Q are made only as of the date of this report, and Walmart undertakes no obligation to update any such statements to reflect subsequent events or circumstances. 35 Table of Contents Item 6. Exhibits The following documents are filed as an exhibit to this Quarterly Report on Form 10-Q: Exhibit 3.1(a) Restated Certificate of Incorporation of the Company dated February 1, 2018 is incorporated herein by reference to Exhibit 3.1 to the Report on Form 8-K filed by the Company on February 1, 2018 Exhibit 3.1(b) Certificate of Amendment to the Restated Certificate of Incorporation of the Company, effective February 23, 2024 is incorporated herein by reference to Exhibit 3.1 to the Report on Form 8-K filed by the Company on February 23, 2024 Exhibit 3.2 Amended and Restated Bylaws of the Company dated November 10, 2022 are incorporated herein by reference to Exhibit 3.1 to the Report on Form 8-K filed by the Company on November 16, 2022 Exhibit 31.1* Chief Executive Officer Section 302 Certification Exhibit 31.2* Chief Financial Officer Section 302 Certification Exhibit 32.1** Chief Executive Officer Section 906 Certification Exhibit 32.2** Chief Financial Officer Section 906 Certification Exhibit 99.1* Opioids-Related Litigation Case Citations and Currently Scheduled Trial Dates Exhibit 101.INS* Inline XBRL Instance Document Exhibit 101.SCH* Inline XBRL Taxonomy Extension Schema Document Exhibit 101.CAL* Inline XBRL Taxonomy Extension Calculation Linkbase Document Exhibit 101.DEF* Inline XBRL Taxonomy Extension Definition Linkbase Document Exhibit 101.LAB* Inline XBRL Taxonomy Extension Label Linkbase Document Exhibit 101.PRE* Inline XBRL Taxonomy Extension Presentation Linkbase Document Exhibit 104 The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended October 31, 2024, formatted in Inline XBRL (included in Exhibit 101) * Filed herewith as an Exhibit. ** Furnished herewith as an Exhibit. 36 Table of Contents SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.   WALMART INC. Date: December 6, 2024 By: /s/ C. Douglas McMillon C. Douglas McMillon President and Chief Executive Officer (Principal Executive Officer) Date: December 6, 2024 By: /s/ John David Rainey John David Rainey Executive Vice President and Chief Financial Officer (Principal Financial Officer) Date: December 6, 2024 By: /s/ David M. Chojnowski David M. Chojnowski Senior Vice President and Controller (Principal Accounting Officer) 37

Predict whether the return of QUAL over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: positive

Explanation: The actual 21-day forward return for QUAL starting 2025-01-07 was +2.39%, which classifies as 'positive'.


XLU over past 60 days: cumulative return +3.4%, annualized vol 12.5%. Market regime: bull.

Question:
Asset: XLU
Historical prices (past 60 trading days): start=39.94, end=41.29, cumulative_return=+3.4%, annualized_volatility=12.5%
Macro context: {'fed_funds_rate': 4.33, 'cpi_yoy': 324.245, 'unemployment': 4.4, 'gdp_growth_qoq': 24026.834, 't10y2y_spread': 0.54, 't10y3m_spread': 0.04, 'breakeven_10y': 2.38, 'hy_oas': 2.79, 'ig_oas': 0.77, 'ted_spread': 0.09, 'mortgage_30y': 6.35, 'vix': 15.720000267028809}
Market regime: bull
Recent filing/news:
[Kaggle 2025-09-05] ["Trump Warns of \u2018Fairly Substantial\u2019 Tariff on Semiconductors. What It Means for Chip Stocks. President Donald Trump said a tariff on imports of chips is coming \u201cvery shortly\u201d for companies that aren\u2019t shifting production to the U.S.", "Inside eBay\u2019s Quest to Become an AI Leader How the 30-year-old e-commerce giant is going all-in on artificial intelligence, hoping the technology can help it update its image and beat mounting competition.", "Trump Basks in Tech Leaders\u2019 Spending Vows at White House Dinner (Bloomberg) \u2014 Meta Platforms Inc.\u2019s (META) Mark Zuckerberg and Apple Inc.\u2019s (AAPL) Tim Cook joined tech industry leaders in touting their pledges to boost spending in the US on artificial intelligence during a dinner hosted by President Donald Trump that highlighted his deepening relationship with Silicon Valley. Most Read from Bloomberg One of World\u2019s Most Liveable Cities Ends Euro-a-Day Travel Pass Chicago\u2019s Citadel Center for Sale 3 Years After Miami Move Philadelphia Transit Cuts Portend \u2018Mayhem\u2019 for Commutes and Regional Economy One-Way Streets Are the Wrong Way to Tame Downtown Traffic Self-Driving Cars Take a Turn Toward the Villainous, in Movies and Real Life In his opening remarks, Trump addressed a key concern of tech companies: ensuring there\u2019s enough energy to meet surging power demands from the data centers behind the AI boom. \u201cWe\u2019re making it very easy for you in terms of electric capacity and getting it for you, getting your permits,\u201d Trump said in the White House State Dining Room. \u201cWe\u2019re leading China by a lot, by a really, by a great amount.\u201d Thursday\u2019s dinner marked a rare gathering in Washington of top executives and founders from some of the world\u2019s most valuable tech companies \u2014 all vying for an edge in the emerging field of AI. Attendees also included OpenAI Inc.\u2019s (OPAI.PVT) Sam Altman, Alphabet Inc.\u2019s (GOOG, GOOGL) Sundar Pichai and co-founder Sergey Brin, and Microsoft Corp.\u2019s (MSFT) Satya Nadella and Bill Gates. The president went around the table asking executives to talk about their plans. Corporate leaders took turns highlighting their efforts to expand in the US, with each expressing gratitude for administration policies they see as bolstering efforts to advance AI. Trump asked Zuckerberg to speak first. \u201cAll of the companies here are building, just making huge investments in the country in order to build out data centers and infrastructure to power the next wave of innovation,\u201d the Meta CEO told Trump. Pressed by the president on how much his company was investing, Zuckerberg said \u201cat least $600 billion\u201d through 2028. \u201cThat\u2019s a lot,\u201d Trump said. In recent days, the president has touted a massive data center Meta is building in Louisiana that will cost $50 billion. Trump has drawn tech executives into his orbit with an agenda aimed at lowering tax

Predict whether the return of XLU over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: positive

Explanation: The actual 21-day forward return for XLU starting 2025-09-18 was +6.82%, which classifies as 'positive'.


ETH-USD over past 60 days: cumulative return -38.3%, annualized vol 68.5%. Market regime: sideways.

Question:
Asset: ETH-USD
Historical prices (past 60 trading days): start=3634.10, end=2241.98, cumulative_return=-38.3%, annualized_volatility=68.5%
Macro context: {'fed_funds_rate': 4.33, 'cpi_yoy': 319.785, 'unemployment': 4.2, 'gdp_growth_qoq': 23548.21, 't10y2y_spread': 0.29, 't10y3m_spread': -0.07, 'breakeven_10y': 2.34, 'hy_oas': 2.88, 'ig_oas': 0.87, 'ted_spread': 0.09, 'mortgage_30y': 6.76, 'vix': 21.93000030517578}
Market regime: sideways
Recent filing/news:
[Kaggle 2023-12-19]

Predict whether the return of ETH-USD over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: negative

Explanation: The actual 21-day forward return for ETH-USD starting 2025-03-06 was -9.09%, which classifies as 'negative'.


ACWI over past 60 days: cumulative return -0.8%, annualized vol 14.8%. Market regime: bear.

Question:
Asset: ACWI
Historical prices (past 60 trading days): start=115.36, end=114.49, cumulative_return=-0.8%, annualized_volatility=14.8%
Macro context: {'fed_funds_rate': 4.33, 'cpi_yoy': 319.785, 'unemployment': 4.2, 'gdp_growth_qoq': 23548.21, 't10y2y_spread': 0.34, 't10y3m_spread': -0.09, 'breakeven_10y': 2.38, 'hy_oas': 3.55, 'ig_oas': 0.97, 'ted_spread': 0.09, 'mortgage_30y': 6.65, 'vix': 22.280000686645508}
Market regime: bear
Recent filing/news:
[Kaggle 2025-03-31] LTRX Transforms Edge AI Computing by Unveiling Open-Q 8550CS SOM Lantronix, Inc. LTRX introduced its latest offering, the Open-Q 8550CS System-on-Module (SOM). Powered by Qualcomm’s Dragonwing QCS8550 processor, this production-ready module is designed to bring low-power, high-performance AI and Machine Learning capabilities to the Edge computing. This innovation aims to accelerate the development of AI-driven applications across a broad spectrum of industries like smart warehousing, manufacturing, transportation, logistics and retail. Lantronix’s Open-Q 8550CS SOM is built specifically to meet the extreme Edge AI demands, making it an ideal solution for advanced video applications, robotics, drones, industrial automation and smart warehousing. This Lantronix platform exhibits characteristics similar to all its embedded compute technology and delivers a full solution with hardware, software, Device Management, and services, allowing customers to accelerate time to market. Lantronix Open-Q solutions are TAA and NDAA-compliant, ensuring a minimum of 10 years of longevity with strict quality control. With more than 20 years of expertise, LTRX has delivered more than 1,200 hardware and software projects, fostering reliability and innovation. The state-of-the-art solution is a high-performance, power-efficient computing platform designed with best-in-class AI capabilities, security and connectivity. It has a powerful 4nm Octa-core CPU (up to 3.2 GHz), Adreno A740 GPU, dual AI engines, and strong security. Supports Wi-Fi 7 (5.8Gbps), up to 8GB LPDDR5 RAM, 128GB UFS storage, and runs Android 13 & Linux Yocto Kirkstone. It also features a Computer Vision Engine, multiple camera/display ports, and Qualcomm Sensing Hub 3.0 for top-tier AI, multimedia, and connectivity performance. This platform boosts video conferencing, AGV pathing, smart camera quality and Edge AI scalability with octa-core computing and 48 AI TOPS tensor performance. The platform handles 3D rendering and computer vision with Adreno 740 GPU, ray tracing and 4K/8K video support while enabling Edge AI with 2.5G and 10G Ethernet. To support developers in evaluating and integrating the Open-Q 8550CS SOM, Lantronix offers a comprehensive Development Kit. This kit provides a fully-featured carrier board exposing all I/O interfaces, support for multiple camera configurations (C-PHY and D-PHY MIPI CSI, GMSL), AI accelerators for always-on applications (voice, contextual data, sensors) and comprehensive connectivity options, including Gigabit Ethernet, GNSS and DisplayPort. This kit is designed to reduce development time, allowing developers to quickly test, validate and deploy AI-powered solutions. Apart from hardware and software, Lantronix Engineering Services provides turn-key product development support for Open-Q platforms and kits. With expertise in more than 1,500 successful products, the team specializes in camera tuning, voice control, machine learning, RF and mechanical design and powe

Predict whether the return of ACWI over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: flat

Explanation: The actual 21-day forward return for ACWI starting 2025-04-01 was +0.53%, which classifies as 'flat'.


CSHI over past 60 days: cumulative return -0.8%, annualized vol 4.2%. Market regime: bear.

Question:
Asset: CSHI
Historical prices (past 60 trading days): start=46.81, end=46.45, cumulative_return=-0.8%, annualized_volatility=4.2%
Macro context: {'fed_funds_rate': 4.33, 'cpi_yoy': 320.302, 'unemployment': 4.2, 'gdp_growth_qoq': 23770.976, 't10y2y_spread': 0.33, 't10y3m_spread': -0.27, 'breakeven_10y': 2.18, 'hy_oas': 4.45, 'ig_oas': 1.14, 'ted_spread': 0.09, 'mortgage_30y': 6.64, 'vix': 43.34999847412109}
Market regime: bear

Predict whether the return of CSHI over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: positive

Explanation: The actual 21-day forward return for CSHI starting 2025-04-07 was +1.65%, which classifies as 'positive'.


XLY over past 60 days: cumulative return -4.6%, annualized vol 29.9%. Market regime: sideways.

Question:
Asset: XLY
Historical prices (past 60 trading days): start=111.99, end=106.80, cumulative_return=-4.6%, annualized_volatility=29.9%
Macro context: {'fed_funds_rate': 4.33, 'cpi_yoy': 320.62, 'unemployment': 4.3, 'gdp_growth_qoq': 23770.976, 't10y2y_spread': 0.47, 't10y3m_spread': 0.08, 'breakeven_10y': 2.32, 'hy_oas': 3.09, 'ig_oas': 0.94, 'ted_spread': 0.09, 'mortgage_30y': 6.76, 'vix': 18.21999931335449}
Market regime: sideways
Recent filing/news:
[Kaggle 2025-05-13] Alnylam Pharmaceuticals (NasdaqGS:ALNY) To Present Pivotal TTR Franchise Data At Heart Failure Congress In May 2025, Alnylam Pharmaceuticals announced its plan to present new data from its transthyretin amyloidosis (TTR) franchise at the Heart Failure 2025 Congress, alongside securing broader international approvals for its therapeutic vutrisiran (AMVUTTRA). During the same month, the overall market rallied due to positive developments in U.S.-China trade relations, with major indexes experiencing substantial gains. Alnylam's 5.63% rise over the period likely reflects investor optimism towards its recent product announcements and earnings improvements, aligning with broader market upward trends driven by eased international trade tensions. Alnylam Pharmaceuticals has 1 warning sign we think you should know about. Find companies with promising cash flow potential yet trading below their fair value. The recent announcement by Alnylam Pharmaceuticals about presenting new data at Heart Failure 2025 Congress and gaining wider international approvals for vutrisiran could significantly bolster investor confidence in the company's growth trajectory. Given the expanded indication for AMVUTTRA in ATTR cardiomyopathy, the potential for increased revenue is substantial. This aligns with the company's aim to achieve sustainable profitability, despite current earnings being at US$269.7 million. Additionally, analysts forecast future earnings to improve, with expected revenue reaching several billion dollars, indicating growth prospects fueled by new product launches and expanding market share. Over the past three years, Alnylam's total shareholder return, including share price and dividends, was 101.13%. This robust performance compares favorably against the market's 8% return over the past year. Additionally, Alnylam outperformed the US Biotechs industry, which experienced a 15.3% decline in the same time frame. These figures underscore Alnylam's relative strength and investor optimism toward its pipeline and strategic initiatives. The enthusiasm generated by Alnylam's recent developments is also reflected in the stock's price movement. The shares currently trade at a discount to the consensus analyst price target of US$320.56, suggesting potential upside if future earnings and revenue growth materialize as expected. However, despite the positive sentiment, the stock's price-to-sales ratio remains above both industry and peer averages, indicating a premium valuation. As such, the price movement in conjunction with analyst forecasts highlights both potential growth opportunities and the inherent risks associated with Alnylam's current market positioning. Navigate through the intricacies of Alnylam Pharmaceuticals with our comprehensive balance sheet health report here. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to

Predict whether the return of XLY over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: negative

Explanation: The actual 21-day forward return for XLY starting 2025-05-14 was -2.02%, which classifies as 'negative'.


SOL-USD over past 60 days: cumulative return +35.1%, annualized vol 67.8%. Market regime: sideways.

Question:
Asset: SOL-USD
Historical prices (past 60 trading days): start=129.42, end=174.91, cumulative_return=+35.1%, annualized_volatility=67.8%
Macro context: {'fed_funds_rate': 4.33, 'cpi_yoy': 320.62, 'unemployment': 4.3, 'gdp_growth_qoq': 23770.976, 't10y2y_spread': 0.51, 't10y3m_spread': 0.15, 'breakeven_10y': 2.33, 'hy_oas': 3.4, 'ig_oas': 0.93, 'ted_spread': 0.09, 'mortgage_30y': 6.86, 'vix': 22.290000915527344}
Market regime: sideways
Recent filing/news:
[Kaggle 2023-12-19]

Predict whether the return of SOL-USD over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: negative

Explanation: The actual 21-day forward return for SOL-USD starting 2025-05-27 was -16.44%, which classifies as 'negative'.


DOT-USD over past 60 days: cumulative return -21.4%, annualized vol 85.5%. Market regime: bull.

Question:
Asset: DOT-USD
Historical prices (past 60 trading days): start=4.50, end=3.54, cumulative_return=-21.4%, annualized_volatility=85.5%
Macro context: {'fed_funds_rate': 3.87, 'cpi_yoy': 325.063, 'unemployment': 4.5, 'gdp_growth_qoq': 24055.749, 't10y2y_spread': 0.55, 't10y3m_spread': 0.18, 'breakeven_10y': 2.29, 'hy_oas': 3.02, 'ig_oas': 0.82, 'ted_spread': 0.09, 'mortgage_30y': 6.22, 'vix': 17.280000686645508}
Market regime: bull
Recent filing/news:
[Kaggle 2023-12-19]

Predict whether the return of DOT-USD over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: flat

Explanation: The actual 21-day forward return for DOT-USD starting 2025-11-12 was +0.00%, which classifies as 'flat'.


XLRE over past 60 days: cumulative return +3.4%, annualized vol 11.6%. Market regime: bull.

Question:
Asset: XLRE
Historical prices (past 60 trading days): start=40.60, end=42.00, cumulative_return=+3.4%, annualized_volatility=11.6%
Macro context: {'fed_funds_rate': 4.12, 'cpi_yoy': 324.245, 'unemployment': 4.4, 'gdp_growth_qoq': 24055.749, 't10y2y_spread': 0.53, 't10y3m_spread': 0.12, 'breakeven_10y': 2.28, 'hy_oas': 2.8, 'ig_oas': 0.77, 'ted_spread': 0.09, 'mortgage_30y': 6.19, 'vix': 15.789999961853027}
Market regime: bull
Recent filing/news:
[SEC 10-Q PG 2025-10-24] pg-20250930 0000080424 6/30 2026 Q1 false http://fasb.org/us-gaap/2025#OtherAssetsNoncurrent http://fasb.org/us-gaap/2025#PrepaidExpenseAndOtherAssetsCurrent http://fasb.org/us-gaap/2025#OtherAssetsNoncurrent http://fasb.org/us-gaap/2025#PrepaidExpenseAndOtherAssetsCurrent http://fasb.org/us-gaap/2025#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2025#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2025#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2025#AccountsPayableCurrent http://fasb.org/us-gaap/2025#AccountsPayableCurrent xbrli:shares iso4217:USD iso4217:USD xbrli:shares pg:segment xbrli:pure pg:country pg:taxable_jurisdiction pg:audit pg:employee 0000080424 2025-07-01 2025-09-30 0000080424 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0000080424 pg:A0.110NotesDue2026Member 2025-07-01 2025-09-30 0000080424 pg:A3.250EURNotesDue2026Member 2025-07-01 2025-09-30 0000080424 pg:A4.875EURNotesDueMay2027Member 2025-07-01 2025-09-30 0000080424 pg:A1.200NotesDue2028Member 2025-07-01 2025-09-30 0000080424 pg:A3.150EURONotesDue2028Member 2025-07-01 2025-09-30 0000080424 pg:A1.250NotesDue2029Member 2025-07-01 2025-09-30 0000080424 pg:A1.800NotesDue2029Member 2025-07-01 2025-09-30 0000080424 pg:A6.250GBPNotesDueJanuary2030Member 2025-07-01 2025-09-30 0000080424 pg:A0.350NotesDue2030Member 2025-07-01 2025-09-30 0000080424 pg:A0.230NotesDue2031Member 2025-07-01 2025-09-30 0000080424 pg:A3.250EURNotesDue2031Member 2025-07-01 2025-09-30 0000080424 pg:A5.250GBPNotesDueJanuary2033Member 2025-07-01 2025-09-30 0000080424 pg:A3.200EURNotesDue2034Member 2025-07-01 2025-09-30 0000080424 pg:A1.875NotesDue2038Member 2025-07-01 2025-09-30 0000080424 pg:A0.900NotesDue2041Member 2025-07-01 2025-09-30 0000080424 2025-09-30 0000080424 2024-07-01 2024-09-30 0000080424 2025-06-30 0000080424 us-gaap:CommonStockMember 2025-06-30 0000080424 us-gaap:PreferredStockMember 2025-06-30 0000080424 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2025-06-30 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0000080424 us-gaap:TreasuryStockCommonMember 2025-06-30 0000080424 us-gaap:RetainedEarningsMember 2025-06-30 0000080424 us-gaap:NoncontrollingInterestMember 2025-06-30 0000080424 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0000080424 us-gaap:NoncontrollingInterestMember 2025-07-01 2025-09-30 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-07-01 2025-09-30 0000080424 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0000080424 us-gaap:TreasuryStockCommonMember 2025-07-01 2025-09-30 0000080424 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0000080424 us-gaap:PreferredStockMember 2025-07-01 2025-09-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2025-07-01 2025-09-30 0000080424 us-gaap:CommonStockMember 2025-09-30 0000080424 us-gaap:PreferredStockMember 2025-09-30 0000080424 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2025-09-30 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-09-30 0000080424 us-gaap:TreasuryStockCommonMember 2025-09-30 0000080424 us-gaap:RetainedEarningsMember 2025-09-30 0000080424 us-gaap:NoncontrollingInterestMember 2025-09-30 0000080424 us-gaap:CommonStockMember 2024-06-30 0000080424 us-gaap:PreferredStockMember 2024-06-30 0000080424 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2024-06-30 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0000080424 us-gaap:TreasuryStockCommonMember 2024-06-30 0000080424 us-gaap:RetainedEarningsMember 2024-06-30 0000080424 us-gaap:NoncontrollingInterestMember 2024-06-30 0000080424 2024-06-30 0000080424 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0000080424 us-gaap:NoncontrollingInterestMember 2024-07-01 2024-09-30 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0000080424 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0000080424 us-gaap:TreasuryStockCommonMember 2024-07-01 2024-09-30 0000080424 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0000080424 us-gaap:PreferredStockMember 2024-07-01 2024-09-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2024-07-01 2024-09-30 0000080424 us-gaap:CommonStockMember 2024-09-30 0000080424 us-gaap:PreferredStockMember 2024-09-30 0000080424 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2024-09-30 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0000080424 us-gaap:TreasuryStockCommonMember 2024-09-30 0000080424 us-gaap:RetainedEarningsMember 2024-09-30 0000080424 us-gaap:NoncontrollingInterestMember 2024-09-30 0000080424 2024-09-30 0000080424 us-gaap:OperatingSegmentsMember us-gaap:ProductConcentrationRiskMember pg:FabricCareMember us-gaap:SalesRevenueNetMember pg:FabricHomeCareSegmentMember 2025-07-01 2025-09-30 0000080424 us-gaap:OperatingSegmentsMember us-gaap:ProductConcentrationRiskMember pg:FabricCareMember us-gaap:SalesRevenueNetMember pg:FabricHomeCareSegmentMember 2024-07-01 2024-09-30 0000080424 us-gaap:OperatingSegmentsMember us-gaap:ProductConcentrationRiskMember pg:HomeCareMember us-gaap:SalesRevenueNetMember pg:FabricHomeCareSegmentMember 2025-07-01 2025-09-30 0000080424 us-gaap:OperatingSegmentsMember us-gaap:ProductConcentrationRiskMember pg:HomeCareMember us-gaap:SalesRevenueNetMember pg:FabricHomeCareSegmentMember 2024-07-01 2024-09-30 0000080424 us-gaap:OperatingSegmentsMember us-gaap:ProductConcentrationRiskMember pg:HairCareMember us-gaap:SalesRevenueNetMember pg:BeautySegmentMember 2025-07-01 2025-09-30 0000080424 us-gaap:OperatingSegmentsMember us-gaap:ProductConcentrationRiskMember pg:HairCareMember us-gaap:SalesRevenueNetMember pg:BeautySegmentMember 2024-07-01 2024-09-30 0000080424 us-gaap:OperatingSegmentsMember us-gaap:ProductConcentrationRiskMember pg:Baby [...TRUNCATED...] ectors on December 13, 2022, pursuant to authority granted by shareholders at the annual meeting on October 13, 2009) (Incorporated by reference to Exhibit (3-2) of the Company’s Current Report on Form 8-K filed December 13, 2022) 4.1 Indenture, dated as of September 3, 2009, between the Company and Deutsche Bank Trust Company Americas, as Trustee (Incorporated by reference to Exhibit (4-1) of the Company's Annual Report on Form 10-K for the year ended June 30, 2015) 10.1 The Procter & Gamble Company 2025 Stock and Incentive Compensation Plan *+ 10.2 Short-Term Achievement Reward Program *+ 10.3 Performance Stock Program Summary *+ 10.4 Long-Term Incentive Program Summary *+ 10.5 Regulations of the Compensation and Leadership Development Committee for The Procter & Gamble 2025 Stock and incentive Compensation Plan, The Procter & Gamble 2019 Stock and Incentive Compensation Plan and The Procter & Gamble 2014 Stock and Incentive Compensation Plan. *+ 10.6 Retirement Plan Restoration Program Summary *+ 10.7 Form of STAR Stock Option Award Agreement *+ 10.8 Form of Director Annual RSU Award Agreement *+ 10.9 Form of Director Annual RSU Award Agreement (Deferred) *+ 10.10 Form of Director RSU Award Agreement (Quarterly Fees) *+ 10.11 Form of PSU Award Agreement *+ 10.12 Form of Deferred PSU Award Agreement *+ 10.13 Form of LTIP RSU Award Agreement *+ 10.14 Form of LTIP Stock Option Award Agreement *+ 10.15 Form of Special RSU Award Agreement *+ 10.16 Form of Retirement Restoration Plan RSU Award Agreement *+ 31.1 Rule 13a-14(a)/15d-14(a) Certification – Chief Executive Officer + 31.2 Rule 13a-14(a)/15d-14(a) Certification – Chief Financial Officer + 32.1 Section 1350 Certifications – Chief Executive Officer + 32.2 Section 1350 Certifications – Chief Financial Officer + 101.SCH (1) Inline XBRL Taxonomy Extension Schema Document 101.CAL (1) Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF (1) Inline XBRL Taxonomy Definition Linkbase Document 101.LAB (1) Inline XBRL Taxonomy Extension Label Linkbase Document 101.PRE (1) Inline XBRL Taxonomy Extension Presentation Linkbase Document 104  Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101) The Procter & Gamble Company 27 * Compensatory plan or arrangement + Filed herewith (1) Pursuant to Rule 406T of Regulation S-T, this information is furnished and not filed for purposes of Sections 11 or 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections. Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized. THE PROCTER & GAMBLE COMPANY October 24, 2025 /s/ MATTHEW W. JANZARUK Date (Matthew W. Janzaruk) Senior Vice President - Chief Accounting Officer (Principal Accounting Officer)

Predict whether the return of XLRE over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: flat

Explanation: The actual 21-day forward return for XLRE starting 2025-10-28 was -0.77%, which classifies as 'flat'.


BIL over past 60 days: cumulative return +0.7%, annualized vol 0.2%. Market regime: bear.

Question:
Asset: BIL
Historical prices (past 60 trading days): start=87.42, end=88.01, cumulative_return=+0.7%, annualized_volatility=0.2%
Macro context: {'fed_funds_rate': 4.33, 'cpi_yoy': 320.302, 'unemployment': 4.2, 'gdp_growth_qoq': 23770.976, 't10y2y_spread': 0.52, 't10y3m_spread': 0.14, 'breakeven_10y': 2.2, 'hy_oas': 4.26, 'ig_oas': 1.18, 'ted_spread': 0.09, 'mortgage_30y': 6.62, 'vix': 37.560001373291016}
Market regime: bear

Predict whether the return of BIL over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: flat

Explanation: The actual 21-day forward return for BIL starting 2025-04-14 was +0.23%, which classifies as 'flat'.


ACWI over past 60 days: cumulative return +4.7%, annualized vol 11.9%. Market regime: sideways.

Question:
Asset: ACWI
Historical prices (past 60 trading days): start=116.59, end=122.11, cumulative_return=+4.7%, annualized_volatility=11.9%
Macro context: {'fed_funds_rate': 4.33, 'cpi_yoy': 319.679, 'unemployment': 4.2, 'gdp_growth_qoq': 23548.21, 't10y2y_spread': 0.26, 't10y3m_spread': 0.21, 'breakeven_10y': 2.45, 'hy_oas': 2.66, 'ig_oas': 0.79, 'ted_spread': 0.09, 'mortgage_30y': 6.87, 'vix': 15.350000381469728}
Market regime: sideways
Recent filing/news:
[SEC 10-K CAT 2025-02-14] cat-20241231 0000018230 FALSE 2024 FY 50 33.33 33.33 33.33 33.33 33.33 33.33 http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligationsCurrent http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligationsCurrent http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligations http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligations http://fasb.org/us-gaap/2024#AccountsPayableCurrent http://fasb.org/us-gaap/2024#AccountsPayableCurrent http://fasb.org/us-gaap/2024#AccountsPayableCurrent http://fasb.org/us-gaap/2024#AccountsPayableCurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#Revenues http://fasb.org/us-gaap/2024#Revenues http://fasb.org/us-gaap/2024#Revenues http://fasb.org/us-gaap/2024#OtherOperatingIncomeExpenseNet http://fasb.org/us-gaap/2024#OtherOperatingIncomeExpenseNet http://fasb.org/us-gaap/2024#OtherOperatingIncomeExpenseNet iso4217:USD xbrli:shares iso4217:USD xbrli:shares cat:dealer cat:country cat:distributor xbrli:pure cat:facilities utr:Rate cat:group_president cat:segment 0000018230 2024-01-01 2024-12-31 0000018230 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0000018230 cat:A5.3DebenturesDueSeptember152035Member 2024-01-01 2024-12-31 0000018230 2024-12-31 0000018230 cat:MachineryEnergyTransportationMember 2024-01-01 2024-12-31 0000018230 cat:MachineryEnergyTransportationMember 2023-01-01 2023-12-31 0000018230 cat:MachineryEnergyTransportationMember 2022-01-01 2022-12-31 0000018230 cat:FinancialProductsMember 2024-01-01 2024-12-31 0000018230 cat:FinancialProductsMember 2023-01-01 2023-12-31 0000018230 cat:FinancialProductsMember 2022-01-01 2022-12-31 0000018230 2023-01-01 2023-12-31 0000018230 2022-01-01 2022-12-31 0000018230 cat:AllOtherExcludingFinancialProductsMember 2024-01-01 2024-12-31 0000018230 cat:AllOtherExcludingFinancialProductsMember 2023-01-01 2023-12-31 0000018230 cat:AllOtherExcludingFinancialProductsMember 2022-01-01 2022-12-31 0000018230 2023-12-31 0000018230 cat:FinancialProductsMember 2024-12-31 0000018230 cat:FinancialProductsMember 2023-12-31 0000018230 cat:MachineryEnergyTransportationMember 2024-12-31 0000018230 cat:MachineryEnergyTransportationMember 2023-12-31 0000018230 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2021-12-31 0000018230 us-gaap:TreasuryStockCommonMember 2021-12-31 0000018230 us-gaap:RetainedEarningsMember 2021-12-31 0000018230 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000018230 us-gaap:NoncontrollingInterestMember 2021-12-31 0000018230 2021-12-31 0000018230 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0000018230 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0000018230 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0000018230 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0000018230 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-12-31 0000018230 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2022-12-31 0000018230 us-gaap:TreasuryStockCommonMember 2022-12-31 0000018230 us-gaap:RetainedEarningsMember 2022-12-31 0000018230 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000018230 us-gaap:NoncontrollingInterestMember 2022-12-31 0000018230 2022-12-31 0000018230 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0000018230 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-12-31 0000018230 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0000018230 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0000018230 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-12-31 0000018230 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-12-31 0000018230 us-gaap:TreasuryStockCommonMember 2023-12-31 0000018230 us-gaap:RetainedEarningsMember 2023-12-31 0000018230 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000018230 us-gaap:NoncontrollingInterestMember 2023-12-31 0000018230 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0000018230 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-12-31 0000018230 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-12-31 0000018230 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0000018230 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-12-31 0000018230 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-12-31 0000018230 us-gaap:TreasuryStockCommonMember 2024-12-31 0000018230 us-gaap:RetainedEarningsMember 2024-12-31 0000018230 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0000018230 us-gaap:NoncontrollingInterestMember 2024-12-31 0000018230 country:US 2024-01-01 2024-12-31 0000018230 cat:CountriesOutsideUnitedStatesMember 2024-01-01 2024-12-31 0000018230 cat:PerkinsMember 2024-01-01 2024-12-31 0000018230 cat:FgWilsonMember 2024-01-01 2024-12-31 0000018230 srt:MaximumMember 2024-12-31 0000018230 2025-01-01 2024-12-31 0000018230 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-12-31 0000018230 us-gaap:PerformanceSharesMember 2024-01-01 2024-12-31 0000018230 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-12-31 0000018230 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0000018230 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0000018230 us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0000018230 us-gaap:PerformanceSharesMember 2023-12-31 0000018230 us-gaap:RestrictedStockUnitsRSUMember 2024-12-31 0000018230 us-gaap:PerformanceSharesMember 2024-12-31 0000018230 cat:StockOptionsandShareAppreciationRightsSARsMember 2024-01-01 2024-12-31 0000018230 cat:StockOptionsandShareAppreciationRightsSARsMember 2023-01-01 2023-12-31 0000018230 cat:StockOptionsandShareApprecia [...TRUNCATED...] ulation Linkbase Document 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document 104 Cover Page Interactive File (embedded within the Inline XBRL document and included in Exhibit 101) _________________________________________ *Management contracts and compensatory plans and arrangements required to be filed as exhibits pursuant to Item 15(b) of this report. The agreements and other documents filed as exhibits to this report are not intended to provide factual information or other disclosure other than with respect to the terms of the agreements or other documents themselves, and you should not rely on them for that purpose. In particular, any representations and warranties made by us in these agreements or other documents were made solely within the specific context of the relevant agreement or document and may not describe the actual state of affairs as of the date they were made or at any other time. Item 16.  Form 10-K Summary. None. 129 Table of Contents Form 10-K   SIGNATURES   Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.     CATERPILLAR INC.   Registrant     February 14, 2025 By: /s/ Derek Owens     Derek Owens Chief Legal Officer and General Counsel   Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.       Chairman of the Board  and Chief Executive Officer February 14, 2025 /s/ D. James Umpleby III   D. James Umpleby III       February 14, 2025 /s/ Andrew R.J. Bonfield Chief Financial Officer Andrew R.J. Bonfield     February 14, 2025 /s/ William E. Schaupp Vice President and Chief Accounting Officer   William E. Schaupp             February 14, 2025 /s/ Daniel M. Dickinson Director   Daniel M. Dickinson   February 14, 2025 /s/ James C. Fish, Jr. Director James C. Fish, Jr.       130 Table of Contents February 14, 2025 /s/ Gerald Johnson Director   Gerald Johnson   February 14, 2025 /s/ Nazzic S. Keene Director Nazzic S. Keene       February 14, 2025 /s/ David W. MacLennan Director   David W. MacLennan   February 14, 2025 /s/ Judith F. Marks Director Judith F. Marks February 14, 2025 /s/ Debra L. Reed-Klages Presiding Director Debra L. Reed-Klages       February 14, 2025 /s/ Susan C. Schwab Director   Susan C. Schwab             February 14, 2025 /s/ Rayford Wilkins, Jr. Director   Rayford Wilkins, Jr.   131

Predict whether the return of ACWI over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: negative

Explanation: The actual 21-day forward return for ACWI starting 2025-02-19 was -4.64%, which classifies as 'negative'.


XRP-USD over past 60 days: cumulative return +118.0%, annualized vol 114.7%. Market regime: sideways.

Question:
Asset: XRP-USD
Historical prices (past 60 trading days): start=1.12, end=2.44, cumulative_return=+118.0%, annualized_volatility=114.7%
Macro context: {'fed_funds_rate': 4.33, 'cpi_yoy': 318.961, 'unemployment': 4.0, 'gdp_growth_qoq': 23548.21, 't10y2y_spread': 0.41, 't10y3m_spread': 0.42, 'breakeven_10y': 2.44, 'hy_oas': 2.8, 'ig_oas': 0.84, 'ted_spread': 0.09, 'mortgage_30y': 6.93, 'vix': 18.709999084472656}
Market regime: sideways
Recent filing/news:
[Kaggle 2023-12-19]

Predict whether the return of XRP-USD over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: negative

Explanation: The actual 21-day forward return for XRP-USD starting 2025-01-15 was -2.35%, which classifies as 'negative'.


PALL over past 60 days: cumulative return +9.7%, annualized vol 36.1%. Market regime: bull.

Question:
Asset: PALL
Historical prices (past 60 trading days): start=91.66, end=100.58, cumulative_return=+9.7%, annualized_volatility=36.1%
Macro context: {'fed_funds_rate': 4.33, 'cpi_yoy': 323.291, 'unemployment': 4.3, 'gdp_growth_qoq': 24026.834, 't10y2y_spread': 0.65, 't10y3m_spread': -0.02, 'breakeven_10y': 2.42, 'hy_oas': 2.78, 'ig_oas': 0.78, 'ted_spread': 0.09, 'mortgage_30y': 6.58, 'vix': 14.619999885559082}
Market regime: bull

Predict whether the return of PALL over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: positive

Explanation: The actual 21-day forward return for PALL starting 2025-08-27 was +15.27%, which classifies as 'positive'.


LINK-USD over past 60 days: cumulative return -38.2%, annualized vol 88.0%. Market regime: sideways.

Question:
Asset: LINK-USD
Historical prices (past 60 trading days): start=23.40, end=14.45, cumulative_return=-38.2%, annualized_volatility=88.0%
Macro context: {'fed_funds_rate': 4.33, 'cpi_yoy': 319.785, 'unemployment': 4.2, 'gdp_growth_qoq': 23548.21, 't10y2y_spread': 0.2, 't10y3m_spread': -0.19, 'breakeven_10y': 2.36, 'hy_oas': 2.94, 'ig_oas': 0.89, 'ted_spread': 0.09, 'mortgage_30y': 6.76, 'vix': 22.780000686645508}
Market regime: sideways
Recent filing/news:
[Kaggle 2023-12-19]

Predict whether the return of LINK-USD over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: positive

Explanation: The actual 21-day forward return for LINK-USD starting 2025-03-04 was +3.90%, which classifies as 'positive'.


^VIX over past 60 days: cumulative return +13.5%, annualized vol 123.8%. Market regime: sideways.

Question:
Asset: ^VIX
Historical prices (past 60 trading days): start=16.35, end=18.56, cumulative_return=+13.5%, annualized_volatility=123.8%
Macro context: {'fed_funds_rate': 3.88, 'cpi_yoy': 325.063, 'unemployment': 4.5, 'gdp_growth_qoq': 24055.749, 't10y2y_spread': 0.58, 't10y3m_spread': 0.11, 'breakeven_10y': 2.22, 'hy_oas': 3.1, 'ig_oas': 0.84, 'ted_spread': 0.09, 'mortgage_30y': 6.26, 'vix': 18.559999465942383}
Market regime: sideways
Recent filing/news:
[SEC 10-Q NVDA 2025-11-19] nvda-20251026 0001045810 1/25 2026 Q3 FALSE 478 469 278 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure nvda:investment nvda:segment 0001045810 2025-01-27 2025-10-26 0001045810 2025-11-14 0001045810 2025-07-28 2025-10-26 0001045810 2024-07-29 2024-10-27 0001045810 2024-01-29 2024-10-27 0001045810 2025-10-26 0001045810 2025-01-26 0001045810 us-gaap:CommonStockMember 2025-07-27 0001045810 us-gaap:AdditionalPaidInCapitalMember 2025-07-27 0001045810 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-07-27 0001045810 us-gaap:RetainedEarningsMember 2025-07-27 0001045810 2025-07-27 0001045810 us-gaap:RetainedEarningsMember 2025-07-28 2025-10-26 0001045810 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-07-28 2025-10-26 0001045810 us-gaap:CommonStockMember 2025-07-28 2025-10-26 0001045810 us-gaap:AdditionalPaidInCapitalMember 2025-07-28 2025-10-26 0001045810 us-gaap:CommonStockMember 2025-10-26 0001045810 us-gaap:AdditionalPaidInCapitalMember 2025-10-26 0001045810 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-10-26 0001045810 us-gaap:RetainedEarningsMember 2025-10-26 0001045810 us-gaap:CommonStockMember 2024-07-28 0001045810 us-gaap:AdditionalPaidInCapitalMember 2024-07-28 0001045810 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-28 0001045810 us-gaap:RetainedEarningsMember 2024-07-28 0001045810 2024-07-28 0001045810 us-gaap:RetainedEarningsMember 2024-07-29 2024-10-27 0001045810 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-29 2024-10-27 0001045810 us-gaap:CommonStockMember 2024-07-29 2024-10-27 0001045810 us-gaap:AdditionalPaidInCapitalMember 2024-07-29 2024-10-27 0001045810 us-gaap:CommonStockMember 2024-10-27 0001045810 us-gaap:AdditionalPaidInCapitalMember 2024-10-27 0001045810 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-10-27 0001045810 us-gaap:RetainedEarningsMember 2024-10-27 0001045810 2024-10-27 0001045810 us-gaap:CommonStockMember 2025-01-26 0001045810 us-gaap:AdditionalPaidInCapitalMember 2025-01-26 0001045810 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-26 0001045810 us-gaap:RetainedEarningsMember 2025-01-26 0001045810 us-gaap:RetainedEarningsMember 2025-01-27 2025-10-26 0001045810 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-27 2025-10-26 0001045810 us-gaap:CommonStockMember 2025-01-27 2025-10-26 0001045810 us-gaap:AdditionalPaidInCapitalMember 2025-01-27 2025-10-26 0001045810 us-gaap:CommonStockMember 2024-01-28 0001045810 us-gaap:AdditionalPaidInCapitalMember 2024-01-28 0001045810 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-28 0001045810 us-gaap:RetainedEarningsMember 2024-01-28 0001045810 2024-01-28 0001045810 us-gaap:RetainedEarningsMember 2024-01-29 2024-10-27 0001045810 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-29 2024-10-27 0001045810 us-gaap:CommonStockMember 2024-01-29 2024-10-27 0001045810 us-gaap:AdditionalPaidInCapitalMember 2024-01-29 2024-10-27 0001045810 us-gaap:CostOfSalesMember 2025-07-28 2025-10-26 0001045810 us-gaap:CostOfSalesMember 2024-07-29 2024-10-27 0001045810 us-gaap:CostOfSalesMember 2025-01-27 2025-10-26 0001045810 us-gaap:CostOfSalesMember 2024-01-29 2024-10-27 0001045810 us-gaap:ResearchAndDevelopmentExpenseMember 2025-07-28 2025-10-26 0001045810 us-gaap:ResearchAndDevelopmentExpenseMember 2024-07-29 2024-10-27 0001045810 us-gaap:ResearchAndDevelopmentExpenseMember 2025-01-27 2025-10-26 0001045810 us-gaap:ResearchAndDevelopmentExpenseMember 2024-01-29 2024-10-27 0001045810 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2025-07-28 2025-10-26 0001045810 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-07-29 2024-10-27 0001045810 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2025-01-27 2025-10-26 0001045810 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-01-29 2024-10-27 0001045810 nvda:RSUsPSUsandMarketbasedPSUsMember 2025-01-26 0001045810 nvda:RSUsPSUsandMarketbasedPSUsMember 2025-01-27 2025-10-26 0001045810 nvda:RSUsPSUsandMarketbasedPSUsMember 2025-10-26 0001045810 us-gaap:EmployeeStockMember 2025-01-27 2025-10-26 0001045810 us-gaap:USTreasurySecuritiesMember 2025-10-26 0001045810 us-gaap:CorporateDebtSecuritiesMember 2025-10-26 0001045810 us-gaap:MoneyMarketFundsMember 2025-10-26 0001045810 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2025-10-26 0001045810 us-gaap:CertificatesOfDepositMember 2025-10-26 0001045810 us-gaap:ForeignGovernmentDebtMember 2025-10-26 0001045810 nvda:MarketableSecuritiesWithFairValueAdjustmentsRecordedInOtherComprehensiveIncomeMember 2025-10-26 0001045810 nvda:PubliclyHeldEquitySecuritiesMember 2025-10-26 0001045810 2025-01-27 2025-04-27 0001045810 us-gaap:CorporateDebtSecuritiesMember 2025-01-26 0001045810 us-gaap:USTreasurySecuritiesMember 2025-01-26 0001045810 us-gaap:MoneyMarketFundsMember 2025-01-26 0001045810 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2025-01-26 0001045810 us-gaap:ForeignGovernmentDebtMember 2025-01-26 0001045810 us-gaap:CertificatesOfDepositMember 2025-01-26 0001045810 nvda:MarketableSecuritiesWithFairValueAdjustmentsRecordedInOtherComprehensiveIncomeMember 2025-01-26 0001045810 nvda:PubliclyHeldEquitySecuritiesMember 2025-01-26 0001045810 nvda:IntangibleAssetsArisingFromBusinessCombinationMember 2025-10-26 0001045810 nvda:IntangibleAssetsArisingFromBusinessCombinationMember 2025-01-26 0001045810 nvda:PatentsAndLicensedTechnologyMember 2025-10-26 0001045810 nvda:PatentsAndLicensedTechnologyMember 2025-01-26 0001045810 nvda:CustomerOneMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2025-01-27 2025-10-26 0001045810 nvda:CustomerTwoMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2025-01-27 2025-10-26 0001045810 nvda:CustomerThreeMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2025-01-27 2025-10-26 0001045810 nvda:CustomerFourMember us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember 2025-01-27 2025-10-26 0001045810 nvda:Cust [...TRUNCATED...] President, Operations Adoption 9/9/2025 309,840 12/31/2026 Donald Robertson Vice President and Chief Accounting Officer Adoption 9/18/2025 138,042 * 12/31/2026 Ajay Puri Executive Vice President, Worldwide Field Operations Adoption 9/19/2025 1,000,000 6/24/2026 * Includes 38,042 shares from future vests of equity awards, and the actual number of shares to be sold will be net of shares withheld by the Company for taxes. 42 Item 6. Exhibits Exhibit No.  Exhibit Description 31.1* Certification of Chief Executive Officer as required by Rule 13a-14(a) of the Securities Exchange Act of 1934 31.2* Certification of Chief Financial Officer as required by Rule 13a-14(a) of the Securities Exchange Act of 1934 32.1#* Certification of Chief Executive Officer as required by Rule 13a-14(b) of the Securities Exchange Act of 1934 32.2#* Certification of Chief Financial Officer as required by Rule 13a-14(b) of the Securities Exchange Act of 1934 101.INS* Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. 101.SCH* Inline XBRL Taxonomy Extension Schema Document 101.CAL* Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF* Inline XBRL Taxonomy Extension Definition Linkbase Document 101.LAB* Inline XBRL Taxonomy Extension Labels Linkbase Document 101.PRE* Inline XBRL Taxonomy Extension Presentation Linkbase Document 104 Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. * Filed herewith. # In accordance with Item 601(b)(32)(ii) of Regulation S-K and SEC Release Nos. 33-8238 and 34-47986, Final Rule: Management's Reports on Internal Control Over Financial Reporting and Certification of Disclosure in Exchange Act Periodic Reports, the certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Quarterly Report on Form 10-Q and will not be deemed “filed” for purpose of Section 18 of the Exchange Act. Such certifications will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference. Copies of above exhibits not contained herein are available to any shareholder upon written request to: Investor Relations: NVIDIA Corporation, 2788 San Tomas Expressway, Santa Clara, CA 95051. 43 Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: November 19, 2025   NVIDIA Corporation  By:    /s/ Colette M. Kress   Colette M. Kress   Executive Vice President and Chief Financial Officer (Duly Authorized Officer and Principal Financial Officer) 44

Predict whether the return of ^VIX over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: negative

Explanation: The actual 21-day forward return for ^VIX starting 2025-11-26 was -20.88%, which classifies as 'negative'.


BNB-USD over past 60 days: cumulative return +10.8%, annualized vol 28.6%. Market regime: bull.

Question:
Asset: BNB-USD
Historical prices (past 60 trading days): start=644.68, end=714.32, cumulative_return=+10.8%, annualized_volatility=28.6%
Macro context: {'fed_funds_rate': 4.33, 'cpi_yoy': 323.291, 'unemployment': 4.3, 'gdp_growth_qoq': 24026.834, 't10y2y_spread': 0.58, 't10y3m_spread': 0.03, 'breakeven_10y': 2.38, 'hy_oas': 2.88, 'ig_oas': 0.77, 'ted_spread': 0.09, 'mortgage_30y': 6.58, 'vix': 15.09000015258789}
Market regime: bull
Recent filing/news:
[Kaggle 2023-12-19]

Predict whether the return of BNB-USD over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: flat

Explanation: The actual 21-day forward return for BNB-USD starting 2025-08-18 was +0.00%, which classifies as 'flat'.


VNQ over past 60 days: cumulative return +5.0%, annualized vol 17.5%. Market regime: sideways.

Question:
Asset: VNQ
Historical prices (past 60 trading days): start=82.83, end=86.95, cumulative_return=+5.0%, annualized_volatility=17.5%
Macro context: {'fed_funds_rate': 4.33, 'cpi_yoy': 319.785, 'unemployment': 4.2, 'gdp_growth_qoq': 23548.21, 't10y2y_spread': 0.26, 't10y3m_spread': -0.08, 'breakeven_10y': 2.31, 'hy_oas': 3.19, 'ig_oas': 0.91, 'ted_spread': 0.09, 'mortgage_30y': 6.65, 'vix': 19.89999961853028}
Market regime: sideways

Predict whether the return of VNQ over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: negative

Explanation: The actual 21-day forward return for VNQ starting 2025-03-20 was -3.89%, which classifies as 'negative'.


CSHI over past 60 days: cumulative return +1.3%, annualized vol 1.4%. Market regime: sideways.

Question:
Asset: CSHI
Historical prices (past 60 trading days): start=47.00, end=47.62, cumulative_return=+1.3%, annualized_volatility=1.4%
Macro context: {'fed_funds_rate': 4.33, 'cpi_yoy': 321.435, 'unemployment': 4.1, 'gdp_growth_qoq': 23770.976, 't10y2y_spread': 0.45, 't10y3m_spread': -0.04, 'breakeven_10y': 2.28, 'hy_oas': 3.18, 'ig_oas': 0.88, 'ted_spread': 0.09, 'mortgage_30y': 6.84, 'vix': 20.81999969482422}
Market regime: sideways

Predict whether the return of CSHI over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: flat

Explanation: The actual 21-day forward return for CSHI starting 2025-06-16 was +0.29%, which classifies as 'flat'.


IYR over past 60 days: cumulative return +0.8%, annualized vol 20.8%. Market regime: sideways.

Question:
Asset: IYR
Historical prices (past 60 trading days): start=92.09, end=92.86, cumulative_return=+0.8%, annualized_volatility=20.8%
Macro context: {'fed_funds_rate': 4.33, 'cpi_yoy': 321.435, 'unemployment': 4.1, 'gdp_growth_qoq': 23770.976, 't10y2y_spread': 0.48, 't10y3m_spread': 0.05, 'breakeven_10y': 2.31, 'hy_oas': 3.12, 'ig_oas': 0.87, 'ted_spread': 0.09, 'mortgage_30y': 6.85, 'vix': 17.15999984741211}
Market regime: sideways

Predict whether the return of IYR over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: flat

Explanation: The actual 21-day forward return for IYR starting 2025-06-10 was +0.08%, which classifies as 'flat'.


IYR over past 60 days: cumulative return +14.0%, annualized vol 17.3%. Market regime: sideways.

Question:
Asset: IYR
Historical prices (past 60 trading days): start=82.52, end=94.07, cumulative_return=+14.0%, annualized_volatility=17.3%
Macro context: {'fed_funds_rate': 4.33, 'cpi_yoy': 322.169, 'unemployment': 4.3, 'gdp_growth_qoq': 24026.834, 't10y2y_spread': 0.47, 't10y3m_spread': -0.07, 'breakeven_10y': 2.33, 'hy_oas': 2.8, 'ig_oas': 0.8, 'ted_spread': 0.09, 'mortgage_30y': 6.67, 'vix': 16.3799991607666}
Market regime: sideways

Predict whether the return of IYR over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: flat

Explanation: The actual 21-day forward return for IYR starting 2025-07-04 was +0.73%, which classifies as 'flat'.


BNO over past 60 days: cumulative return -1.9%, annualized vol 24.0%. Market regime: sideways.

Question:
Asset: BNO
Historical prices (past 60 trading days): start=29.28, end=28.71, cumulative_return=-1.9%, annualized_volatility=24.0%
Macro context: {'fed_funds_rate': 3.64, 'cpi_yoy': 326.031, 'unemployment': 4.4, 'gdp_growth_qoq': 24055.749, 't10y2y_spread': 0.68, 't10y3m_spread': 0.46, 'breakeven_10y': 2.24, 'hy_oas': 2.84, 'ig_oas': 0.79, 'ted_spread': 0.09, 'mortgage_30y': 6.18, 'vix': 13.470000267028809}
Market regime: sideways

Predict whether the return of BNO over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: flat

Explanation: The actual 21-day forward return for BNO starting 2025-12-25 was +0.82%, which classifies as 'flat'.


SOL-USD over past 60 days: cumulative return +4.5%, annualized vol 56.8%. Market regime: sideways.

Question:
Asset: SOL-USD
Historical prices (past 60 trading days): start=148.05, end=154.74, cumulative_return=+4.5%, annualized_volatility=56.8%
Macro context: {'fed_funds_rate': 4.33, 'cpi_yoy': 321.435, 'unemployment': 4.1, 'gdp_growth_qoq': 23770.976, 't10y2y_spread': 0.52, 't10y3m_spread': -0.17, 'breakeven_10y': 2.29, 'hy_oas': 2.96, 'ig_oas': 0.86, 'ted_spread': 0.09, 'mortgage_30y': 6.77, 'vix': 16.729999542236328}
Market regime: sideways
Recent filing/news:
[Kaggle 2023-12-19]

Predict whether the return of SOL-USD over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: positive

Explanation: The actual 21-day forward return for SOL-USD starting 2025-07-01 was +40.00%, which classifies as 'positive'.


VLUE over past 60 days: cumulative return +1.5%, annualized vol 12.9%. Market regime: sideways.

Question:
Asset: VLUE
Historical prices (past 60 trading days): start=107.09, end=108.73, cumulative_return=+1.5%, annualized_volatility=12.9%
Macro context: {'fed_funds_rate': 4.33, 'cpi_yoy': 319.679, 'unemployment': 4.2, 'gdp_growth_qoq': 23548.21, 't10y2y_spread': 0.21, 't10y3m_spread': 0.18, 'breakeven_10y': 2.44, 'hy_oas': 2.66, 'ig_oas': 0.81, 'ted_spread': 0.09, 'mortgage_30y': 6.87, 'vix': 15.100000381469728}
Market regime: sideways
Recent filing/news:
[SEC 10-K JNJ 2025-02-13] jnj-20241229 0000200406 2024 FY false Johnson & Johnson http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#AccountsPayableCurrent http://fasb.org/us-gaap/2024#AccountsPayableCurrent P25Y http://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpense iso4217:USD xbrli:shares iso4217:USD xbrli:shares jnj:Employee xbrli:pure jnj:Segment iso4217:EUR iso4217:GBP jnj:StockBasedCompensationPlans jnj:segment jnj:claimant jnj:cases 0000200406 2024-01-01 2024-12-29 0000200406 us-gaap:CommonStockMember 2024-01-01 2024-12-29 0000200406 jnj:A1.150NotesDueNovember2028Member 2024-01-01 2024-12-29 0000200406 jnj:A3.20NotesDueNovember2032Member 2024-01-01 2024-12-29 0000200406 jnj:A1.650NotesDue2035Member 2024-01-01 2024-12-29 0000200406 jnj:A3.350NotesDueNovember2036Member 2024-01-01 2024-12-29 0000200406 jnj:A3.550NotesDueNovember2044Member 2024-01-01 2024-12-29 0000200406 2024-06-30 0000200406 2025-02-06 0000200406 2024-12-29 0000200406 2023-12-31 0000200406 2023-01-02 2023-12-31 0000200406 2022-01-03 2023-01-01 0000200406 2022-01-02 0000200406 us-gaap:RetainedEarningsMember 2022-01-02 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-02 0000200406 us-gaap:CommonStockMember 2022-01-02 0000200406 us-gaap:TreasuryStockCommonMember 2022-01-02 0000200406 us-gaap:RetainedEarningsMember 2022-01-03 2023-01-01 0000200406 us-gaap:TreasuryStockCommonMember 2022-01-03 2023-01-01 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-03 2023-01-01 0000200406 2023-01-01 0000200406 us-gaap:RetainedEarningsMember 2023-01-01 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 0000200406 us-gaap:CommonStockMember 2023-01-01 0000200406 us-gaap:TreasuryStockCommonMember 2023-01-01 0000200406 us-gaap:RetainedEarningsMember 2023-01-02 2023-12-31 0000200406 us-gaap:TreasuryStockCommonMember 2023-01-02 2023-12-31 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-02 2023-12-31 0000200406 us-gaap:RetainedEarningsMember 2023-12-31 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000200406 us-gaap:CommonStockMember 2023-12-31 0000200406 us-gaap:TreasuryStockCommonMember 2023-12-31 0000200406 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-29 0000200406 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-12-29 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-12-29 0000200406 us-gaap:RetainedEarningsMember 2024-12-29 0000200406 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-29 0000200406 us-gaap:CommonStockMember 2024-12-29 0000200406 us-gaap:TreasuryStockCommonMember 2024-12-29 0000200406 us-gaap:IPOMember jnj:KenvueIncMember 2023-05-08 2023-05-08 0000200406 jnj:KenvueIncMember 2023-05-08 0000200406 2023-05-08 2023-05-08 0000200406 jnj:KenvueIncMember jnj:JohnsonJohnsonMember 2023-05-08 2023-05-08 0000200406 jnj:KenvueIncMember jnj:JohnsonJohnsonMember 2023-07-02 0000200406 jnj:KenvueIncMember 2023-08-23 2023-08-23 0000200406 jnj:KenvueIncMember jnj:JohnsonJohnsonMember 2023-08-23 2023-08-23 0000200406 srt:MaximumMember us-gaap:BuildingAndBuildingImprovementsMember 2024-12-29 0000200406 srt:MinimumMember jnj:LandAndLeaseholdImprovementsMember 2024-12-29 0000200406 srt:MaximumMember jnj:LandAndLeaseholdImprovementsMember 2024-12-29 0000200406 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2024-12-29 0000200406 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2024-12-29 0000200406 srt:MinimumMember us-gaap:SoftwareDevelopmentMember 2024-12-29 0000200406 srt:MaximumMember us-gaap:SoftwareDevelopmentMember 2024-12-29 0000200406 srt:MinimumMember 2024-01-01 2024-12-29 0000200406 srt:MaximumMember 2024-01-01 2024-12-29 0000200406 jnj:PharmaceuticalMember 2024-12-29 0000200406 jnj:PharmaceuticalMember 2023-12-31 0000200406 us-gaap:ShippingAndHandlingMember 2024-01-01 2024-12-29 0000200406 us-gaap:ShippingAndHandlingMember 2023-01-02 2023-12-31 0000200406 us-gaap:ShippingAndHandlingMember 2021-01-04 2022-01-02 0000200406 us-gaap:ProductConcentrationRiskMember us-gaap:ResearchAndDevelopmentExpenseMember 2024-01-01 2024-12-29 0000200406 us-gaap:ProductConcentrationRiskMember us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-02 2023-12-31 0000200406 us-gaap:ProductConcentrationRiskMember us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-03 2023-01-01 0000200406 jnj:YellowJerseyTherapeuticsMember 2024-01-01 2024-12-29 0000200406 2018-12-31 2019-12-29 0000200406 2019-12-30 2021-01-03 0000200406 us-gaap:HeldtomaturitySecuritiesMember us-gaap:CashMember 2024-12-29 0000200406 us-gaap:HeldtomaturitySecuritiesMember us-gaap:SovereignDebtSecuritiesMember 2024-12-29 0000200406 us-gaap:HeldtomaturitySecuritiesMember us-gaap:RepurchaseAgreementsMember 2024-12-29 0000200406 us-gaap:HeldtomaturitySecuritiesMember us-gaap:MoneyMarketFundsMember 2024-12-29 0000200406 us-gaap:HeldtomaturitySecuritiesMember us-gaap:CorporateDebtSecuritiesMember 2024-12-29 0000200406 us-gaap:HeldtomaturitySecuritiesMember us-gaap:BankTimeDepositsMember 2024-12-29 0000200406 us-gaap:HeldtomaturitySecuritiesMember 2024-12-29 0000200406 us-gaap:AvailableforsaleSecuritiesMember us-gaap:USTreasuryAndGovernmentMember 2024-12-29 0000200406 us-gaap:AvailableforsaleSecuritiesMember jnj:OtherSovereignSecuritiesMember 2024-12-29 0000200406 us-gaap:AvailableforsaleSecuritiesMember us-gaap:CorporateDebtSecuritiesMember 2024-12-29 0000200406 us-gaap:AvailableforsaleSecuritiesMember 2024-12-29 0000200406 us-gaap:HeldtomaturitySecuritiesMember us-gaap:CashMember 2023-12-31 0000200406 us-gaap:HeldtomaturitySecuritiesMember us-g [...TRUNCATED...] 12; Incorporated herein by reference to Exhibit 10.2 of the Registrant’s Form 10-Q Quarterly Report for the quarter ended October 1, 2023.* 10(a b ) Johnson & Johnson Executive Officer Cash Severance Policy — Filed with this document.* 19 Johnson & Johnson Stock Trading Policy for Directors, Executive Officers and Insiders (Amended as of April 27, 2023) — Incorporated herein by reference to Exhibit 19 of the Registrant’s Form 10-K Annual Report for the fiscal year ended December 31, 2023. 21 Subsidiaries — Filed with this document. 23 Consent of Independent Registered Public Accounting Firm — Filed with this document. 31.1 Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act — Filed with this document. 31.2 Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act — Filed with this document. 32.1 Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act — Furnished with this document. 32.2 Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act — Furnished with this document. 97 Johnson & Johnson Clawback Policy (effective as of August 8, 2023) — Incorporated herein by reference to Exhibit 97 of the Registrant’s Form 10-K Annual Report for the fiscal year ended December 31, 2023. Exhibit 101: EX-101.INS Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document EX-101.SCH Inline XBRL Taxonomy Extension Schema EX-101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase EX-101.LAB Inline XBRL Taxonomy Extension Label Linkbase EX-101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase EX-101.DEF Inline XBRL Taxonomy Extension Definition Document Exhibit 104: Cover Page Interactive Data File––the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. * Management contract or compensatory plan. ** Paper filing. † Certain exhibits and schedules have been omitted pursuant to Item 601(b)(2)(ii) or 601(b)(10)(iv) of Regulation S-K, as applicable. A copy of any of the Exhibits listed above will be provided without charge to any shareholder submitting a written request specifying the desired exhibit(s) to the Secretary at the principal executive offices of the Company. Pursuant to Item 601(b)(4)(iii)(A) of Regulation S-K, the Company has not filed as exhibits to this Form 10-K certain long-term debt instruments, under which the total amount of securities authorized does not exceed 10% of the total assets of the Company and its subsidiaries on a consolidated basis. The Company hereby agrees to furnish a copy of any such instrument to the SEC upon request. 2024 Annual Report 121

Predict whether the return of VLUE over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: negative

Explanation: The actual 21-day forward return for VLUE starting 2025-02-14 was -3.26%, which classifies as 'negative'.


VEA over past 60 days: cumulative return +6.5%, annualized vol 12.1%. Market regime: bull.

Question:
Asset: VEA
Historical prices (past 60 trading days): start=54.45, end=58.01, cumulative_return=+6.5%, annualized_volatility=12.1%
Macro context: {'fed_funds_rate': 4.33, 'cpi_yoy': 324.245, 'unemployment': 4.4, 'gdp_growth_qoq': 24026.834, 't10y2y_spread': 0.54, 't10y3m_spread': -0.02, 'breakeven_10y': 2.36, 'hy_oas': 2.87, 'ig_oas': 0.8, 'ted_spread': 0.09, 'mortgage_30y': 6.5, 'vix': 15.039999961853027}
Market regime: bull
Recent filing/news:
[Kaggle 2025-09-05] ["Trump Warns of \u2018Fairly Substantial\u2019 Tariff on Semiconductors. What It Means for Chip Stocks. President Donald Trump said a tariff on imports of chips is coming \u201cvery shortly\u201d for companies that aren\u2019t shifting production to the U.S.", "Inside eBay\u2019s Quest to Become an AI Leader How the 30-year-old e-commerce giant is going all-in on artificial intelligence, hoping the technology can help it update its image and beat mounting competition.", "Trump Basks in Tech Leaders\u2019 Spending Vows at White House Dinner (Bloomberg) \u2014 Meta Platforms Inc.\u2019s (META) Mark Zuckerberg and Apple Inc.\u2019s (AAPL) Tim Cook joined tech industry leaders in touting their pledges to boost spending in the US on artificial intelligence during a dinner hosted by President Donald Trump that highlighted his deepening relationship with Silicon Valley. Most Read from Bloomberg One of World\u2019s Most Liveable Cities Ends Euro-a-Day Travel Pass Chicago\u2019s Citadel Center for Sale 3 Years After Miami Move Philadelphia Transit Cuts Portend \u2018Mayhem\u2019 for Commutes and Regional Economy One-Way Streets Are the Wrong Way to Tame Downtown Traffic Self-Driving Cars Take a Turn Toward the Villainous, in Movies and Real Life In his opening remarks, Trump addressed a key concern of tech companies: ensuring there\u2019s enough energy to meet surging power demands from the data centers behind the AI boom. \u201cWe\u2019re making it very easy for you in terms of electric capacity and getting it for you, getting your permits,\u201d Trump said in the White House State Dining Room. \u201cWe\u2019re leading China by a lot, by a really, by a great amount.\u201d Thursday\u2019s dinner marked a rare gathering in Washington of top executives and founders from some of the world\u2019s most valuable tech companies \u2014 all vying for an edge in the emerging field of AI. Attendees also included OpenAI Inc.\u2019s (OPAI.PVT) Sam Altman, Alphabet Inc.\u2019s (GOOG, GOOGL) Sundar Pichai and co-founder Sergey Brin, and Microsoft Corp.\u2019s (MSFT) Satya Nadella and Bill Gates. The president went around the table asking executives to talk about their plans. Corporate leaders took turns highlighting their efforts to expand in the US, with each expressing gratitude for administration policies they see as bolstering efforts to advance AI. Trump asked Zuckerberg to speak first. \u201cAll of the companies here are building, just making huge investments in the country in order to build out data centers and infrastructure to power the next wave of innovation,\u201d the Meta CEO told Trump. Pressed by the president on how much his company was investing, Zuckerberg said \u201cat least $600 billion\u201d through 2028. \u201cThat\u2019s a lot,\u201d Trump said. In recent days, the president has touted a massive data center Meta is building in Louisiana that will cost $50 billion. Trump has drawn tech executives into his orbit with an agenda aimed at lowering tax

Predict whether the return of VEA over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: positive

Explanation: The actual 21-day forward return for VEA starting 2025-09-10 was +2.02%, which classifies as 'positive'.


ITB over past 60 days: cumulative return +8.1%, annualized vol 28.4%. Market regime: bull.

Question:
Asset: ITB
Historical prices (past 60 trading days): start=99.75, end=107.87, cumulative_return=+8.1%, annualized_volatility=28.4%
Macro context: {'fed_funds_rate': 4.09, 'cpi_yoy': 324.245, 'unemployment': 4.4, 'gdp_growth_qoq': 24055.749, 't10y2y_spread': 0.55, 't10y3m_spread': 0.08, 'breakeven_10y': 2.34, 'hy_oas': 2.81, 'ig_oas': 0.77, 'ted_spread': 0.09, 'mortgage_30y': 6.34, 'vix': 16.6299991607666}
Market regime: bull

Predict whether the return of ITB over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: negative

Explanation: The actual 21-day forward return for ITB starting 2025-10-03 was -9.65%, which classifies as 'negative'.


XLB over past 60 days: cumulative return +5.0%, annualized vol 15.5%. Market regime: bull.

Question:
Asset: XLB
Historical prices (past 60 trading days): start=43.17, end=45.33, cumulative_return=+5.0%, annualized_volatility=15.5%
Macro context: {'fed_funds_rate': 4.33, 'cpi_yoy': 324.245, 'unemployment': 4.4, 'gdp_growth_qoq': 24026.834, 't10y2y_spread': 0.59, 't10y3m_spread': 0.03, 'breakeven_10y': 2.37, 'hy_oas': 2.83, 'ig_oas': 0.79, 'ted_spread': 0.09, 'mortgage_30y': 6.5, 'vix': 15.18000030517578}
Market regime: bull
Recent filing/news:
[Kaggle 2025-09-05] ["Trump Warns of \u2018Fairly Substantial\u2019 Tariff on Semiconductors. What It Means for Chip Stocks. President Donald Trump said a tariff on imports of chips is coming \u201cvery shortly\u201d for companies that aren\u2019t shifting production to the U.S.", "Inside eBay\u2019s Quest to Become an AI Leader How the 30-year-old e-commerce giant is going all-in on artificial intelligence, hoping the technology can help it update its image and beat mounting competition.", "Trump Basks in Tech Leaders\u2019 Spending Vows at White House Dinner (Bloomberg) \u2014 Meta Platforms Inc.\u2019s (META) Mark Zuckerberg and Apple Inc.\u2019s (AAPL) Tim Cook joined tech industry leaders in touting their pledges to boost spending in the US on artificial intelligence during a dinner hosted by President Donald Trump that highlighted his deepening relationship with Silicon Valley. Most Read from Bloomberg One of World\u2019s Most Liveable Cities Ends Euro-a-Day Travel Pass Chicago\u2019s Citadel Center for Sale 3 Years After Miami Move Philadelphia Transit Cuts Portend \u2018Mayhem\u2019 for Commutes and Regional Economy One-Way Streets Are the Wrong Way to Tame Downtown Traffic Self-Driving Cars Take a Turn Toward the Villainous, in Movies and Real Life In his opening remarks, Trump addressed a key concern of tech companies: ensuring there\u2019s enough energy to meet surging power demands from the data centers behind the AI boom. \u201cWe\u2019re making it very easy for you in terms of electric capacity and getting it for you, getting your permits,\u201d Trump said in the White House State Dining Room. \u201cWe\u2019re leading China by a lot, by a really, by a great amount.\u201d Thursday\u2019s dinner marked a rare gathering in Washington of top executives and founders from some of the world\u2019s most valuable tech companies \u2014 all vying for an edge in the emerging field of AI. Attendees also included OpenAI Inc.\u2019s (OPAI.PVT) Sam Altman, Alphabet Inc.\u2019s (GOOG, GOOGL) Sundar Pichai and co-founder Sergey Brin, and Microsoft Corp.\u2019s (MSFT) Satya Nadella and Bill Gates. The president went around the table asking executives to talk about their plans. Corporate leaders took turns highlighting their efforts to expand in the US, with each expressing gratitude for administration policies they see as bolstering efforts to advance AI. Trump asked Zuckerberg to speak first. \u201cAll of the companies here are building, just making huge investments in the country in order to build out data centers and infrastructure to power the next wave of innovation,\u201d the Meta CEO told Trump. Pressed by the president on how much his company was investing, Zuckerberg said \u201cat least $600 billion\u201d through 2028. \u201cThat\u2019s a lot,\u201d Trump said. In recent days, the president has touted a massive data center Meta is building in Louisiana that will cost $50 billion. Trump has drawn tech executives into his orbit with an agenda aimed at lowering tax

Predict whether the return of XLB over the next 21 trading days will be: positive (>+1%), negative (<-1%), or flat (within ±1%).

Answer: negative

Explanation: The actual 21-day forward return for XLB starting 2025-09-08 was -2.39%, which classifies as 'negative'.